Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan

Cites (269)

Items 201–269 of 269

1. Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways
   Atul Kumar Goyal, Chiara Poluzzi, Chris D. Willis, James Smythies, Adam Shellard, Thomas Neill, Renato V. Iozzo · 2012 · Journal of Biological Chemistry
2. Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
   Jong Wook Chang, Un‐Beom Kang, Dong‐Hyun Kim, Jae Kyo Yi, Jong Won Lee, Dong‐Young Noh, Cheolju Lee, Myeong‐Hee Yu · 2007 · PROTEOMICS - CLINICAL APPLICATIONS
3. Perlecan Knockdown in Metastatic Prostate Cancer Cells Reduces Heparin-binding Growth Factor Responses in vitro and Tumor Growth in vivo
   Cristiana Savorè, Chu Zhang, Caroline Muir · 2005 · Clinical & Experimental Metastasis
4. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment
   Chunyu Xia, Sheng Yin, Shanshan Xu, Guang‐Yao Ran, Miao Deng, Ling Mei, Xian Tang, Jingdong Rao, Man Li, Zhirong Zhang et al. · 2018 · Theranostics
5. Perlecan in human bone marrow: A growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells
   Gerd Klein · 1995 · Matrix Biology
6. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy
   Stephen M. Douglass, Atul Kumar Goyal, Renato V. Iozzo · 2015 · Connective Tissue Research
7. Human heparanase: a molecular determinant of brain metastasis
   Dario Marchetti, Garth L. Nicolson · 2001 · Advances in Enzyme Regulation
8. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer
   Ivan Fernández‐Vega, Olivia García, Ainara Crespo · 2013 · BMC Cancer
9. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix
   Pnina Bashkin, Ehud Razin, Amiram Eldor, Israël Vlodavsky · 1990 · Blood
10. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line
    Eve Damiens, Ikram El Yazidi‐Belkoura, Joël Mazurier · 1998 · European Journal of Cell Biology
11. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration
    Andrew W. Burr, Kieran Toole, Claire Chapman, Julie E. Hines, Alastair D. Burt · 1998 · The Journal of Pathology
12. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis
    Madhuchhanda Roy, Dario Marchetti · 2008 · Journal of Cellular Biochemistry
13. The human sulfatase 2 inhibitor 2,4‐disulfonylphenyl‐tert‐butylnitrone (OKN‐007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
    Xin Min Zheng, Xiaohong Gai, Shaoshan Han · 2012 · Genes Chromosomes and Cancer
14. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
    Cinzia Lanzi, Giuliana Cassinelli · 2018 · Molecules
15. Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA
    R. Adatia, Adriana Albini, Sebastiano Carlone, Daniela Giunciuglio, Roberto Benelli, L. Santi, Douglas McClain Noonan · 1997 · Annals of Oncology
16. Acute compressive stress activates RHO/ROCK-mediated cellular processes
    Sarah Theresa Boyle, Jasreen Kular, Max Nobis · 2018 · Small GTPases
17. Heparanase: Breaking down barriers in tumors
    Suzanne A. Eccles · 1999 · Nature Medicine
18. Hypoxia Increases Heparanase-Dependent Tumor Cell Invasion, Which Can Be Inhibited by Antiheparanase Antibodies
    Xiaotong T. He, Paul E. Brenchley, Gordon C. Jayson, Lynne Hampson, John Davies, IAN N. HAMPSON · 2004 · Cancer Research
19. 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors
    Weitao Pan, Hua‐Quan Miao, Yong-Jiang Xu et al. · 2005 · Bioorganic & Medicinal Chemistry Letters
20. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomasin situ of the breast
    Knut Engels, Stephen B. Fox, Ruth M. Whitehouse, Kevin C. Gatter, Adrian Llewellyn Harris · 1997 · The Journal of Pathology
21. Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice
    Ravi Sankar Loka, Eric T. Sletten, Uri Barash · 2018 · ACS Applied Materials & Interfaces
22. Heparan Sulfate-Like Proteoglycans Mediate Adhesion of Human Malignant Melanoma A375 Cells to P-Selectin Under Flow
    Yan‐Qing Ma, Jian-Guo Geng · 2000 · The Journal of Immunology
23. A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology?
    Amanda M. Weyers, Bo Yang, Dae Sung Yoon, Jong‐Hwan Park, Fuming Zhang, Kyung‐Bok Lee, Robert J. Linhardt · 2012 · OMICS A Journal of Integrative Biology
24. PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
    Edward Hammond, Ralf Brandt, Keith S. Dredge · 2012 · PLoS ONE
25. Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer
    Jiaojie Wei, Yang Long, Rong Guo, Xinlei Liu, Xian Tang, Jingdong Rao, Sheng Yin, Zhirong Zhang, Man Li, Qin He · 2019 · Acta Pharmaceutica Sinica B
26. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance
    Cinzia Lanzi, Nadia Zaffaroni, Giuliana Cassinelli · 2017 · Current Medicinal Chemistry
27. Promoter hypermethylation correlates with the Hsulf‐1 silencing in human breast and gastric cancer
    Zhao Chen, Jie‐Qing Fan, Jie Li et al. · 2008 · International Journal of Cancer
28. Endorepellin laminin‐like globular 1/2 domains bind Ig3–5 of vascular endothelial growth factor ( VEGF ) receptor 2 and block pro‐angiogenic signaling by VEGFA in endothelial cells
    Chris D. Willis, Chiara Poluzzi, Maurizio Mongiat, Renato V. Iozzo · 2013 · FEBS Journal
29. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma
    Aysegül Ilhan‐Mutlu, Christian Siehs, Anna Sophie Berghoff, Gerda Ricken, Georg Widhalm, Ludwig Wagner, Matthias Preusser · 2015 · Tumor Biology
30. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity
    Ravi Sankar Loka, Fei Yu, Eric T. Sletten, Hien M. Nguyen · 2017 · Chemical Communications
31. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model
    Brian P. Murry, Bryan E. Blust, Amandip Singh, Timothy P. Foster, Dario Marchetti · 2005 · Journal of Cellular Biochemistry
32. Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results
    Eileen Mary O'Reilly, James M. Roach, Paul Justin Miller et al. · 2017 · The Oncologist
33. Heparanase Expression in Circulating Lymphocytes of Breast Cancer Patients Depends on the Presence of the Primary Tumor and/or Systemic Metastasis
    Thérèse Rachell Theodoro, Leandro Luongo Matos, Aleksandra Vanessa Lambiasi Sant Anna · 2007 · Neoplasia
34. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture
    Hiroko Ida‐Yonemochi, Terué Ikarashi, Masaki Nagata · 2001 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
35. Perlecan signaling: Helping hedgehog stimulate prostate cancer growth
    Sumana Datta, Michael Pierce, Milton W. Datta · 2006 · The International Journal of Biochemistry & Cell Biology
36. Transcriptional Activation by NFκB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
    Curtis R. Warren, Brian J. Grindel, Lewis W. Francis, Daniel D. Carson, Mary C. Farach‐Carson · 2014 · Journal of Cellular Biochemistry
37. Neuroendocrine Tumors Show Altered Expression of Chondroitin Sulfate, Glypican 1, Glypican 5, and Syndecan 2 Depending on Their Differentiation Grade
    Olivia García‐Suárez, Beatriz García, Ivan Fernández‐Vega · 2014 · Frontiers in Oncology
38. Enhanced expression of basement‐membrane‐type heparan sulfate proteoglycan in tumor fibro‐myxoid stroma of intrahepatic cholangiocarcinoma
    Hemragul Sabit, Koichi Tsuneyama, Tomonori Shimonishi · 2001 · Pathology International
39. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells
    Brian J. Grindel, Jerahme R. Martinez, Tristen V. Tellman, Daniel A. Harrington, Hamim Zafar, Luay K. Nakhleh, Leland W.K. Chung, Mary C. Farach‐Carson · 2018 · Scientific Reports
40. Essential Contribution of Tumor-derived Perlecan to Epidermal Tumor Growth and Angiogenesis
    Xinnong Jiang, Hinke A.B. Multhaupt, En Chan · 2004 · Journal of Histochemistry & Cytochemistry
41. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma
    Galina M. Kazanskaya, Alexandra Y. Tsidulko, А. М. Волков, Roman Kiselev, Anastasia V. Suhovskih, Кобозев Вячеслав Витальевич, Alekey S. Gaytan, Svetlana V. Aidagulova, А. Л. Кривошапкин, Григорьева Эльвира Витальевна · 2018 · Histochemistry and Cell Biology
42. Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer
    Maristela Peres Rangel, Vanessa Karen de Sá, Tabatha Gutierrez Prieto, João Roberto Maciel Martins, Eloísa Ribeiro Olivieri, Dirce Maria Carraro, Teresa Yae Takagaki, Vera Luíza Capelozzi · 2018 · Glycoconjugate Journal
43. Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin
    Bo Wang, Juan Jia, Xiao Zhang, Eyal Zcharia, Israël Vlodavsky, Gunnar Pejler, Jin‐Ping Li · 2011 · Journal of Allergy and Clinical Immunology
44. Deletion analysis at the DEL‐27, APC and MTS1 loci in bladder cancer: LOH at the DEL‐27 locus on 5p13‐12 is a prognostic marker of tumor progression
    Malte Böhm, Heide Kirch, T. Otto, Herbert Rubben, Ilse Wieland · 1997 · International Journal of Cancer
45. Heparanase and cancer progression: New directions, new promises
    Gil Arvatz, Marina Weissmann, Neta Ilan · 2016 · Human Vaccines & Immunotherapeutics
46. Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers
    Eric T. Sletten, Ravi Sankar Loka, Fei Yu, Hien M. Nguyen · 2017 · Biomacromolecules
47. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies
    Noriko Komatsu, Michihiko Waki, Mayumi Sue, Chikashi Tokuda, Tatsuhiko Kasaoka, Motowo Nakajima, Nobuaki Higashi, Tatsuro Irimura · 2008 · Journal of Immunological Methods
48. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts
    Hitoshi Kurokawa, Ken‐ichi Katsube, Katarzyna A. Podyma‐Inoue · 2003 · Cancer Science
49. Tissue-specificity of heparan sulfate biosynthetic machinery in cancer
    Anastasia V. Suhovskih, Natalya Domanitskaya, Alexandra Y. Tsidulko · 2015 · Cell Adhesion & Migration
50. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx.
    Michael L. Nerlich, Annette Lebeau, Hagedorn Hg · 1998 · PubMed
51. Non‐Anticoagulant Heparin Prodrug Loaded Biodegradable and Injectable Thermoresponsive Hydrogels for Enhanced Anti‐Metastasis Therapy
    Abegaz Tizazu Andrgie, Shewaye Lakew Mekuria, Kefyalew Dagnew Addisu, Balkew Zewge Hailemeskel, Wei‐Hsin Hsu, Hsieh‐Chih Tsai, Juin‐Yih Lai · 2019 · Macromolecular Bioscience
52. Selective heparanase localization in malignant melanoma
    Brian P. Murry, Andrea Greiter‐Wilke, Daniel B. Paulsen · 2005 · International Journal of Oncology
53. Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity
    Antonella Messore, Valentina Noemi Madia, Luca Pescatori et al. · 2018 · Journal of Medicinal Chemistry
54. Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma
    Hamdy Metwaly, Satoshi Maruyama, Manabu Yamazaki · 2012 · Human Pathology
55. Heparanase expression correlates with metastatic capability in human choriocarcinoma
    C Jingting, Z YANGDE, Yi Zhang · 2007 · Gynecologic Oncology
56. Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer
    Amanda MacDonald, Michelle Priess, Jennifer Curran, Jamey R. Guess, Victor Farutin, Ilse Oosterom, Chia Lin Chu, Edward D. Cochran, Lynn Zhang, Kristen M. Getchell et al. · 2018 · Molecular Cancer Therapeutics
57. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
    Michael L. Nerlich, I. Wiest, E Wagner · 1998 · PubMed
58. SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy
    Anh Thu Bui, Fanny Laurent-Tchénio, Maryline Havard, François Dautry, Thierry Tchénio · 2015 · Cell Cycle
59. Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts
    Patrícia Coutinho de Souza, Samantha Mallory, Nataliya Smith · 2015 · PLoS ONE
60. Altered proteoglycan gene expression and the tumor stroma
    Renato V. Iozzo, ILENE R. COHEN · 1994 · Birkhäuser Basel eBooks
61. YAP/TAZ Related BioMechano Signal Transduction and Cancer Metastasis
    Bridget Martinez, Yongchao Yang, Donald Mario Robert Harker, Charles R. Farrar, Harshini Mukundan, Pulak Nath, David Mascareñas · 2019 · Frontiers in Cell and Developmental Biology
62. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts
    Ashwani Khurana, Deok Jung-Beom, Xiaoping He et al. · 2013 · Clinical & Experimental Metastasis
63. Three‐dimensional visualization of perlecan‐rich neoplastic stroma induced concurrently with the invasion of oral squamous cell carcinoma
    Satoshi Maruyama, Yoshihito Shimazu, Tomoo Kudo · 2014 · Journal of Oral Pathology and Medicine
64. Development and Efficacy of NXY-059 for the Treatment of Acute Ischemic Stroke
    Michalis Papadakis, Simon Nagel, Alastair Mitchell Buchan · 2008 · Future Neurology
65. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa
    Mayumi Hasegawa, Jun Cheng, Satoshi Maruyama · 2016 · Pathology - Research and Practice
66. Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer
    Amit Katz, Uri Barash, Ilanit Boyango · 2018 · Oncotarget
67. Abstract 3051: Mechanism of early dissemination and metastasis in Her2+ mammary cancer
    Kathryn L. Harper, María Soledad Sosa, David R. Entenberg et al. · 2017 · Cancer Research
68. 3D QSAR based design of novel substituted urea molecules as heparanase inhibitors
    Raju Bathini, Sabiha Fatima, Sree Kanth Sivan · 2013 · Journal of Pharmacy Research
69. Biologists abandon Popper at their peril
    2000